Global Corneal Endothelial Dystrophy (CED) Epidemiology Forecast Report 2017-2020 & 2030 - ResearchAndMarkets.com

The "Corneal Endothelial Dystrophy (CED) - Epidemiology Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.

This 'Corneal Endothelial Dystrophy (CED) - Epidemiology Forecast - 2030' report delivers an in-depth understanding of the Corneal Endothelial Dystrophy, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Corneal Endothelial Dystrophy Epidemiology

The Corneal Endothelial Dystrophy epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the prevalent patient pool and their trends along with assumptions undertaken.

Key Findings

The total prevalent cases of Corneal Endothelial Dystrophy patients are increasing in 7MM during the study period, i.e. 2017-2030.

The disease epidemiology covered in the report provides historical as well as forecasted Corneal Endothelial Dystrophy symptoms epidemiology segmented as the Total Prevalent cases of Corneal Endothelial Dystrophy, Gender-specific cases of Corneal Endothelial Dystrophy, Age-specific cases of Corneal Endothelial Dystrophy, and Type-specific cases of Corneal Endothelial Dystrophy.

Country Wise- Corneal Endothelial Dystrophy Epidemiology

The total prevalent cases of Corneal Endothelial Dystrophy associated in 7MM countries were 6,194,906 in 2017.

• As per the estimates, the United States has the largest prevalent population of Corneal Endothelial Dystrophy.
• Among the EU5 countries, Germany had the highest prevalent cases of Corneal Endothelial Dystrophy, followed by Italy. On the other hand, the UK had the lowest prevalent cases with 1,472,742 cases in 2017.

Key Topics Covered:

1 Key Insights

2 Executive summary

3 Organizations

4 Epidemiology and Market Methodology

5 Corneal Endothelial Dystrophy (CED): Market Overview at a Glance

5.1 Introduction

5.2 Types of Corneal Dystrophies

5.3 Stages of Fuchs endothelial dystrophy

5.4 Causes

5.5 Signs and Symptoms

5.6 Genetics and Inheritance

5.7 Clinical Presentation

5.8 Pathophysiology

5.9 Prognosis

5.10. Diagnosis

5.10.1 Diagnostic criteria

5.10.2 Differential Diagnosis

7 Epidemiology and Patient Population

7.1 Key Findings

7.2 Assumptions and Rationale

7.3 Total cases of Corneal Endothelial Dystrophy (CED) in 7MM

7.4 United States

7.4.1 Total Prevalent cases of Corneal Endothelial Dystrophy (CED) in the United States

7.4.2 Gender-specific cases of Corneal Endothelial Dystrophy (CED) in the United States

7.4.3 Age-specific cases of Corneal Endothelial Dystrophy (CED) in the United States

7.4.4 Type-specific cases of Corneal Endothelial Dystrophy (CED) in the United States

7.5 EU5 Countries

7.6 Germany

7.7 France

7.8 Italy

7.9 Spain

7.10. UK

7.11 Japan

8 KOL Views

9 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/o5n63n

View source version on businesswire.com: https://www.businesswire.com/news/home/20201204005335/en/